Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4285892
Max Phase: Preclinical
Molecular Formula: C47H69N15O14S
Molecular Weight: 1100.23
Molecule Type: Small molecule
Associated Items:
ID: ALA4285892
Max Phase: Preclinical
Molecular Formula: C47H69N15O14S
Molecular Weight: 1100.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CSCC[C@H](NC(=O)/C=N/O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C)C(N)=O
Standard InChI: InChI=1S/C47H69N15O14S/c1-23(39(48)68)56-42(71)32(17-26-19-51-22-54-26)61-41(70)29(10-6-13-52-47(49)50)59-43(72)31(16-25-18-53-28-9-5-4-8-27(25)28)60-40(69)24(2)57-44(73)33-11-7-14-62(33)45(74)30(12-15-77-3)58-35(64)20-55-76-46-38(67)37(66)36(65)34(21-63)75-46/h4-5,8-9,18-20,22-24,29-34,36-38,46,53,63,65-67H,6-7,10-17,21H2,1-3H3,(H2,48,68)(H,51,54)(H,56,71)(H,57,73)(H,58,64)(H,59,72)(H,60,69)(H,61,70)(H4,49,50,52)/b55-20+/t23-,24-,29-,30-,31-,32-,33-,34+,36+,37-,38-,46+/m0/s1
Standard InChI Key: UBCZKTXZSRHCJG-KPBQEYADSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1100.23 | Molecular Weight (Monoisotopic): 1099.4869 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ng S, Bennett NJ, Schulze J, Gao N, Rademacher C, Derda R.. (2018) Genetically-encoded fragment-based discovery of glycopeptide ligands for DC-SIGN., 26 (19): [PMID:30344001] [10.1016/j.bmc.2018.08.036] |
Source(1):